Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours

NCT00710268 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis

Interventions

DRUG: AZD2281
DRUG: Bevacizumab

Sponsor

AstraZeneca